Experiment 66646

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismOenothera biennis (ONAGRACEAE)
CitationSTEWART,JCM: MORSE,PE: MOSS,M: HORROBIN,DE: BURTON,JL: DOUGLAS,WS: GOULD,DJ: GRATTAN,CEH: HINDSON,TC: ANDERSON,J: JANSEN,CT: KENNEDY,CTC: LINDSKOV,R: STRONG,AMM: WRIGHT,S:. (1991). TREATMENT OF SEVERE AND MODERATELY SEVERE ATOPIC DERMATITIS WITH EVENING PRIMROSE OIL(EPOGAM): A MULTI-CENTRE STUDY.. 2()
Amount utilized
Compound isolated
DiseaseAN OPEN, UNCONTROLLED TRIAL OF THE VALUE OF A SELECTED VARIETY OF EVENING PRIMROSE OIL(EPOGAM SCOTIA PHARMACEUTICALS LTD. GUILFORD, SURREY GU1 1BA) IN SEVERE AND MODERATELY SEVERE ATOPIC DERMATITIS WAS CONDUCTED IN 13 CENTERS. EVENING PRIMROSE OIL WAS USED IN 179 PATIENTS OF WHOM 111 SHOWED IMPROVEMENT IN THEIR OVERALL CONDITION. IMPROVEMENT WAS NOTED IN ALL ASPECTS OF THE DISEASE AND MANY PATIENTS WERE ABLE TO REDUCE THEIR USE OF ORAL STEROIDS, ANTIBIOTICS AND ANTIHISTAMINES AND OF POTENT TOPICAL STEROIDS. EVENING PRIMROSE OIL IS A USEFUL ADDITION TO THE RANGE OF TREATMENTS FOR SEVERE ATOPIC DERMATITIS. A COMMERCIAL PRODUCT, EPOGAM, WAS USED.
Dose amount1.0 GM
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractSEED OIL
GenderGIVEN TO BOTH SEXES